Get the Stockscreener App
14.78
2.60%
0.365
Inmode Ltd stock is traded at $14.78, with a volume of 305.28K.
It is up +2.60% in the last 24 hours and up +9.60% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
See More
Previous Close:
$14.41
Open:
$14.6
24h Volume:
305.28K
Relative Volume:
0.23
Market Cap:
$933.28M
Revenue:
$492.05M
Net Income/Loss:
$197.92M
P/E Ratio:
6.4239
EPS:
2.3
Net Cash Flow:
$176.12M
1W Performance:
+3.68%
1M Performance:
+9.60%
6M Performance:
-14.34%
1Y Performance:
-17.12%
1-Day Range:
$14.48
$14.81
1-Week Range:
$13.86
$14.81
52-Week Range:
$13.14
$19.85
Inmode Ltd Stock (INMD) Company Profile
Compare INMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.77 | 868.09M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
123.39 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.53 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.36 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.01 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.67 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
What drives InMode Ltd. stock priceTriple-digit return opportunities - Autocar Professional
What analysts say about InMode Ltd. stockSuperior stock growth - Autocar Professional
InMode Ltd. Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com
Is InMode Ltd. a good long term investmentFree Capital Efficiency Planning - jammulinksnews.com
What makes InMode Ltd. stock price move sharplyProtected Capital Trading Plan - beatles.ru
When (INMD) Moves Investors should Listen - news.stocktradersdaily.com
Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) - MSN
InMode Ltd.'s (NASDAQ:INMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
InMode Launches Triton in Australia: A New Era in Laser Hair Removal - medianet.com.au
InMode: Margin Pressure, But Optionality Makes It Worth A Look (NASDAQ:INMD) - Seeking Alpha
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M - Kilgore News Herald
InMode stock falls as BTIG maintains Neutral rating amid lowered guidance - Investing.com Canada
InMode Cuts Fiscal 2025 Revenue Outlook - MarketScreener
InMode Ltd. Revises Revenue Guidance for the Full Year 2025 - MarketScreener
Inmode Ltd. Provides Revenue Guidance for the Second Quarter of 2025 - MarketScreener
InMode India Launches IgniteRFDr. Harvinder & Dr. Gurjot Marwah Become First in India to Pioneer RF Aesthetic Technology - ANI News
(INMD) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2024 in InMode LawsuitINMD - ACCESS Newswire
Is InMode Ltd. overvalued or undervalued? - MarketsMojo
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode Ltd. (INMD): A Volatile Play on Institutional Sentiment and Ownership Risk - AInvest
(INMD) Investment Analysis - news.stocktradersdaily.com
Institutional owners may consider drastic measures as InMode Ltd.'s (NASDAQ:INMD) recent US$51m drop adds to long-term losses - simplywall.st
Earnings Are Growing at InMode (NASDAQ:INMD) but Shareholders Still Don't Like Its Prospects - 富途牛牛
InMode Ltd (INMD) Stock Price Up 3.46% on Jun 9 - GuruFocus
Inmode Ltd (INMD): Is This Deeply Undervalued Stock a Hidden Gem? - The Acquirer's Multiple
InMode at Jefferies Conference: Navigating Economic Challenges By Investing.com - Investing.com South Africa
InMode at Jefferies Conference: Navigating Economic Challenges - Investing.com Australia
(INMD) On The My Stocks Page - news.stocktradersdaily.com
Millennium Management LLC Acquires 35,536 Shares of InMode Ltd. (NASDAQ:INMD) - Defense World
Nuveen Asset Management LLC Reduces Holdings in InMode Ltd. (NASDAQ:INMD) - Defense World
InMode CEO addresses shareholder concerns on operations By Investing.com - Investing.com South Africa
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $689,000 Stake in InMode Ltd. (NASDAQ:INMD) - Defense World
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 - GuruFocus
InMode CEO addresses shareholder concerns on operations - Investing.com Australia
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):